When.com Web Search

  1. Ads

    related to: does doxycycline treat std

Search results

  1. Results From The WOW.Com Content Network
  2. US health officials advise using antibiotic as a ‘morning ...

    www.aol.com/news/us-health-officials-advise...

    Officials call the treatment doxy PEP, short for doxycycline postexposure prophylaxis. Doctors can write a prescription for one dose of 200 milligrams of doxycycline to be taken within three days ...

  3. CDC Recommends Antibiotic for Use as 'Morning After Pill' to ...

    www.aol.com/cdc-recommends-antibiotic-morning...

    “[Doxycycline] combats many different bacteria and is our primary treatment for chlamydia, an alternative treatment for syphilis, and has some activity against gonorrhea,” Zucker said.

  4. Doxycycline - Wikipedia

    en.wikipedia.org/wiki/Doxycycline

    Doxycycline is a broad-spectrum antibiotic of the tetracycline class used in the treatment of infections caused by bacteria and certain parasites. [1] It is used to treat bacterial pneumonia, acne, chlamydia infections, Lyme disease, cholera, typhus, and syphilis. [1] It is also used to prevent malaria.

  5. Sudden syphilis retreat in gay men is most likely tied to ...

    www.aol.com/sudden-syphilis-retreat-gay-men...

    A new proven protocol in which doxycycline is used to prevent sexually ... cases increased 1%, to 209,250 diagnoses. Chlamydia remained stable from 2021 to 2023, at about 1.65 million cases ...

  6. Mycoplasma genitalium - Wikipedia

    en.wikipedia.org/wiki/Mycoplasma_genitalium

    The five-day treatment with azithromycin showed no development of antimicrobial resistance. [49] Based on these findings, UK doctors are moving to the 5-day azithromycin regimen. Doxycycline is also still used, and moxifloxacin is used as a second-line treatment in case doxycyline and azithromycin are not able to eradicate the infection.

  7. Microbicides for sexually transmitted infections - Wikipedia

    en.wikipedia.org/wiki/Microbicides_for_sexually...

    Data collected during the CAPRISA 004 study indicate that tenofovir gel provided 51% protection against HSV-2. Tenofovir, developed by Gilead Sciences, is a nucleotide reverse-transcriptase inhibitor (NRTI) which interferes with the replication of HIV and is approved in tablet form for use in combination with other ARVs to treat HIV.